We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GXAI:NASDAQGaxos.ai Inc. Analysis

Data as of 2026-05-21 - not real-time

$1.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Gaxos.ai Inc. (GXAI) is trading at $1.16, well below its 20‑day (1.235) and 200‑day (1.389) moving averages, with a 30‑day volatility of ~44% and a bearish MACD histogram. The stock’s RSI sits at 41.7, hinting at modest downside momentum, while its beta of 0.38 suggests limited correlation with broader market swings. Fundamentally, the company posted a 75% YoY revenue surge to $3.7 M and now holds $11.8 M of cash with zero debt, but it remains deep in the red (negative operating margin of –140% and EBITDA of –$5.9 M).
Recent headlines indicate a material catalyst: analysts have lifted the revenue outlook to $8.7 M after the firm accelerated customer acquisition, and an after‑hours rally of 19% followed the expansion of its Gaxos Labs AI platform. Despite these upside drivers, the stock faces a steep max drawdown of –62% and a price‑to‑book of 0.74, underscoring both valuation appeal and significant risk. The consensus target price of $2.70 implies a potential upside of over 130%, but the lack of profitability and high volatility temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical positioning (price below key SMAs, MACD negative)
  • High short‑term volatility (44% 30‑day)
  • Positive news catalyst but limited immediate price support

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth trajectory and raised forecast to $8.7 M
  • Robust cash balance with zero debt providing runway
  • Undervalued book metrics (PB 0.74) and sizable upside potential per analyst targets

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Need to achieve sustainable profitability (currently large negative margins)
  • Competitive AI‑gaming landscape may pressure margins
  • Long‑run valuation hinges on successful monetization of the Gaxos Labs platform

Key Metrics & Analysis

Financial Health

Revenue Growth7524.20%
Profit Margin-131.27%
ROE-35.81%
ROA-23.77%
P/B Ratio0.7
Op. Cash Flow$-5049858
Free Cash Flow$-3479006
Industry P/E17.0

Technical Analysis

TrendBearish
RSI41.7
Support$1.11
Resistance$1.38
MA 20$1.24
MA 50$1.27
MA 200$1.39
MACDBearish
VolumeStable
Fear & Greed Index90.36

Valuation

Target Price$2.70
Upside/Downside132.76%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.38
Volatility44.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.